Stock NDRA ENDRA LIFE SCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

News ENDRA Life Sciences Inc.

Equities

NDRA

US29273B3024

Market Closed - Nasdaq
Other stock markets
 16:30:01 2024-05-03 EDT 		5-day change 1st Jan Change
0.3267 USD -1.60% Intraday chart for ENDRA Life Sciences Inc. +29.39% -84.59%
03-28 Transcript : ENDRA Life Sciences Inc., Q4 2023 Earnings Call, Mar 28, 2024
03-28 ENDRA Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents
BU
Transcript : ENDRA Life Sciences Inc., Q4 2023 Earnings Call, Mar 28, 2024
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
BU
ENDRA Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024
BU
ENDRA Life Sciences Installs First TAEUS System in the UK
BU
New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences TAEUS System
AQ
New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS System
BU
ENDRA Life Sciences Inc. Welcomes the Adoption of the ICD-10 K76.0 Code for the Diagnosis of Non-Alcoholic Fatty Liver Disease
CI
ENDRA Life Sciences Bolsters TAEUS System Intellectual Property with New Patents in U.S., China and Europe
AQ
ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe
BU
ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS System Technology
AQ
ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology
BU
ENDRA Life Sciences to participate in the Benchmark Company's 12th Annual Discovery One-on-One Investor Conference
AQ
ENDRA Life Sciences to Participate in The Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference
BU
Transcript : ENDRA Life Sciences Inc., Q3 2023 Earnings Call, Nov 14, 2023
ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
BU
ENDRA Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023
AQ
ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NDRA Stock
  4. News ENDRA Life Sciences Inc.